Rare diseases
Investigational molecules
Locations
61 North Beacon Street, 02134-1912, United States
X4 Pharmaceuticals Inc. focuses on clinical research in congenital and acquired forms of primary autoimmune and idiopathic chronic neutropenia, with attention to patients affected by recurrent and serious infections.
The sponsor’s work in this area is centered on restoring circulating neutrophil levels and addressing the clinical burden associated with persistent neutropenia.
X4 Pharmaceuticals Inc. runs clinical trials in conditions such as Immunodeficiency congenital, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Belgium
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
